78 results
8-K
EX-1.1
APLS
Apellis Pharmaceuticals Inc
1 Nov 23
Entry into a Material Definitive Agreement
7:59am
and the Prospectus.
(gg) The Company and each of its subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks
424B5
7v0cwt xo0t1
1 Nov 23
Prospectus supplement for primary offering
7:51am
8-K
EX-10.1
3z258g5wibj oo8shf
2 Aug 22
Entry into a Material Definitive Agreement
4:38pm
8-K
EX-10.1
vj56gml4
27 Jul 22
Entry into a Material Definitive Agreement
7:08am
8-K
EX-1.1
m3gi yu0ss5mb
24 Mar 22
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
8:18pm
424B5
gjhsbq1oljp6nzm1g
24 Mar 22
Prospectus supplement for primary offering
8:02pm
424B5
qton6j39o 2nurzhf534
23 Mar 22
Prospectus supplement for primary offering
5:14pm